Literature DB >> 20601919

Quality of life among acoustic neuroma patients managed by microsurgery, radiation, or observation.

Joanne E Brooker1, Jane M Fletcher, Michael J Dally, Robert J S Briggs, Vincent C Cousins, Robert I Smee, Gregory M Malham, Richard J Kennedy, Sue Burney.   

Abstract

OBJECTIVE: The main aim of this study was to examine differences in quality of life (QoL) among acoustic neuroma patients across the management options of microsurgery, radiation, and observation. Additional aims were to describe QoL and investigate management, medical, and demographic factors that predicted QoL in this patient group. STUDY
DESIGN: Cross-sectional design, using a postal questionnaire.
SETTING: Tertiary referral centers. PATIENTS: Participants included 180 adults diagnosed with, or treated for, a unilateral acoustic neuroma within 5 years of questionnaire distribution. The mean age of participants was 56.5 years, and 107 (59.4%) were female. INTERVENTION(S): Patients' acoustic neuromas were managed with microsurgery, radiation, or observation. MAIN OUTCOME MEASURE(S): Current QoL was measured using the Short Form 12 Version 2 (SF-12), and postmanagement changes in QoL were assessed with the Glasgow Benefit Inventory (GBI).
RESULTS: No significant differences in SF-12 scores were found across microsurgery, radiation, and observation patients. However, microsurgery patients reported more deterioration on the GBI general well-being subscale than radiation patients and more improvement in the GBI social support scale than observation patients. Number of symptoms was a consistent predictor of SF-12 and GBI scores.
CONCLUSION: This is only the second study to use multivariate statistical techniques and a large sample to examine QoL across the acoustic neuroma management options of microsurgery, radiation, and observation. There were few differences in QoL outcomes across management groups. Number of symptoms was an important factor in current QoL and postmanagement changes in QoL.

Entities:  

Mesh:

Year:  2010        PMID: 20601919     DOI: 10.1097/MAO.0b013e3181e8ca55

Source DB:  PubMed          Journal:  Otol Neurotol        ISSN: 1531-7129            Impact factor:   2.311


  4 in total

1.  [Vestibular schwannoma. Part 2: therapy, prognosis, and rehabilitation].

Authors:  W Maier; F Hassepaß; A Aschendorff; R Laszig
Journal:  HNO       Date:  2012-10       Impact factor: 1.284

Review 2.  [Value of different strategies in the treatment of vestibular schwannoma: therapeutic aspects and literature analysis].

Authors:  W Maier; T D Grauvogel; R Laszig; G J Ridder
Journal:  HNO       Date:  2011-05       Impact factor: 1.284

3.  Mastoidectomy and mastoid obliteration with autologous bone graft: a quality of life study.

Authors:  George Kurien; Kate Greeff; Nahla Gomaa; Allan Ho
Journal:  J Otolaryngol Head Neck Surg       Date:  2013-09-23

Review 4.  The Glasgow Benefit Inventory: a systematic review of the use and value of an otorhinolaryngological generic patient-recorded outcome measure.

Authors:  J Hendry; A Chin; I R C Swan; M A Akeroyd; G G Browning
Journal:  Clin Otolaryngol       Date:  2016-02-07       Impact factor: 2.597

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.